comparemela.com

Latest Breaking News On - Serum institute of india adar poonawalla - Page 5 : comparemela.com

Adar Poonawalla talks about facing threats from chief ministers, powerful leaders in India over vaccines

Immediate lockdown necessary to curb Covid spread in India, says Anthony Fauci On the surface and by that extension on social media, all s well with Serum Institute of India s Adar Poonawalla. Had an excellent meeting with all our partners & stakeholders in the U.K. Meanwhile, pleased to state that Covishield s production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days, he tweeted a few days after taking off to the U.K. But a little while before this, his interview given to The Times of London, had already been reduced to a series of quotable quotes.

Centre grants Y category security to Serum Institute CEO Adar Poonawalla amid threats over Covishield supplies

Centre grants Y category security to Serum Institute CEO Adar Poonawalla amid threats over Covishield supplies Adar Poonawalla, the CEO of Serum Institute of India (SII) gets Y category security cover from the Centre BusinessToday.In | April 29, 2021 | Updated 09:22 IST CEO of Serum Institute of India Adar Poonawalla Chief Executive Officer of the Pune-based Serum Institute of India Adar Poonawalla will get Y category security from the Centre. The Central Reserve Police Force (CRPF) will provide this security cover to Poonawalla. This decision by the Union government came after the director, government and regulatory affairs at Serum Institute of India Prakash Kumar Singh wrote to the Union Home Minister Amit Shah on April 16.

Balasaheb Thorat to donate his one year MLA fund to CM for Maharashtra s fight against COVID-19

Maharashtra cabinet minister Balasaheb Thorat Balasaheb Thorat to donate his one year salary to CM fund for Maharashtra s fight against COVID-19 ANI | Updated: Apr 29, 2021 17:11 IST Mumbai (Maharashtra) [India], April 29 (ANI): Ahead of the next phase of the Covid-19 vaccination drive in the country, which is scheduled to begin from May 1, Maharashtra cabinet minister and senior Congress leader Balasaheb Thorat said that he will donate his one-year salary to Chief Minister relief fund for the fight against COVID-19. He said that Covid has taken a serious form and we have implemented strict rules but the role of vaccine is important in all this. Congress President Sonia Gandhi has demanded to provide free vaccine for all, so yesterday all the three parties together decided to give free vaccine.

MHA to provide Y category security to Serum Institute CEO Adar Poonawalla

MHA to provide Y category security to Serum Institute CEO Adar Poonawalla MHA to provide Y category security to Serum Institute CEO Adar Poonawalla NEW DELHI : The Ministry of Home Affairs (MHA) on Wednesday informed that CEO of Serum Institute of India Adar Poonawalla will be provided with Y category security across the country by the Central Reserve Police Force (CRPF). This comes after the SII’s announcement to reduce the price of its COVID-19 vaccine ‘Covishield’ from Rs 400 to Rs 300 per dose for states. Covishield, one of the two COVID-19 vaccines used in India’s COVID-19 vaccination drive, is being manufactured by SII.

Amid threats, Centre provides Y category security to SII CEO Adar Poonawalla

Amid threats, Centre provides Y category security to SII CEO Adar Poonawalla Covishield, one of the two COVID-19 vaccines used in India s COVID-19 vaccination drive, is being manufactured by SII. File photo/ANI Updated: Apr 28, 2021, 10:35 PM IST The Ministry of Home Affairs (MHA) on Wednesday informed that CEO of Serum Institute of India Adar Poonawalla will be provided with Y category security across the country by the Central Reserve Police Force (CRPF). Speaking to news agency ANI, a government official informed on the condition of anonymity, MHA has issued orders to provide Y category security on all India basis to Adar Poonawalla, CEO of Serum Institute of India. CRPF will provide security.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.